According to a new analysis, PLND does not impact recurrence-free survival but may reduce metastatic spread in intermediate- and high-risk prostate cancer. The benefit of PLND is most evident in ...
Fifteen-year outcomes of external radiation with or without 6 months of neoadjuvant deprivation therapy for intermediate risk prostate cancer. This is an ASCO Meeting Abstract from the 2025 ASCO ...
MedPage Today on MSN
No Prostate Cancer Survival Benefit With More Extensive Lymph Node Assessment
Long-term follow-up consistent with earlier report, a hint of benefit in high-grade diseas ...
Removing lymph nodes during cancer surgery has saved countless lives in many tumour types. Yet recent research is challenging parts of this long-standing practice. Imagine your body’s immune defences ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results